Organon (OGN) Receivables - Net (2020 - 2026)
Organon (OGN) recorded quarterly Receivables - Net of $1.4 billion in Q1 2026, up 3.98% quarter-over-quarter from $1.3 billion in Q4 2025, and down 5.01% on a YoY basis from $1.5 billion in Q1 2025.
Organon (OGN) Receivables - Net (2020 - 2026) Analysis & Trends
Organon's Receivables - Net history runs 7 years deep, the most recent figure standing at $1.4 billion for Q1 2026.
- In Q1 2026, Receivables - Net fell 5.01% year-over-year to $1.4 billion; the TTM figure through Mar 2026 stood at $1.4 billion (down 5.01% YoY), while the FY2025 annual figure was $1.3 billion, down 1.99% from the prior year.
- Receivables - Net was $1.4 billion for Q1 2026 at Organon, up from $1.3 billion in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $1.7 billion in Q4 2023 to a low of $1.3 billion in Q1 2022.
- Historically, Receivables - Net has averaged $1.5 billion across 5 years, with a median of $1.5 billion in 2025.
- The sharpest annual moves came in 2022 and 2024: Receivables - Net jumped 30.89% in 2022, then fell 22.13% in 2024.
- A 5-year view of Receivables - Net shows it stood at $1.5 billion in 2022, then grew by 18.24% to $1.7 billion in 2023, then retreated by 22.13% to $1.4 billion in 2024, then retreated by 1.99% to $1.3 billion in 2025, then rose by 3.98% to $1.4 billion in 2026.
- The last three Receivables - Net figures came in at $1.4 billion (Q1 2026), $1.3 billion (Q4 2025), and $1.5 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 93,026,132.38 Bn | 93,026,127.42 Bn | 7.76 Bn |
| 2 | Eli Lilly | 1,022.62 Bn | 1,017.34 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 570.65 Bn | 548.59 Bn | 15.96 Bn |
| 4 | AbbVie | 398.73 Bn | 389.38 Bn | 10.78 Bn |
| 5 | Merck | 295.53 Bn | 289.88 Bn | 12.09 Bn |
| 6 | Amgen | 186.30 Bn | 174.26 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 155.93 Bn | 148.21 Bn | 5.52 Bn |
| 8 | Pfizer | 146.09 Bn | 133.32 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 114.98 Bn | 104.53 Bn | 8.07 Bn |
| 10 | Organon | 3.49 Bn | 2.37 Bn | 783.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.38 Bn |
| Mar 31, 2026 | 1.38 Bn |
| Dec 31, 2025 | 1.33 Bn |
| Dec 31, 2025 | 1.33 Bn |
| Sep 30, 2025 | 1.48 Bn |
| Sep 30, 2025 | 1.48 Bn |
| Jun 30, 2025 | 1.48 Bn |
| Jun 30, 2025 | 1.48 Bn |
| Mar 31, 2025 | 1.46 Bn |
| Mar 31, 2025 | 1.46 Bn |
| Dec 31, 2024 | 1.36 Bn |
| Dec 31, 2024 | 1.36 Bn |
| Sep 30, 2024 | 1.69 Bn |
| Sep 30, 2024 | 1.69 Bn |
| Jun 30, 2024 | 1.62 Bn |
| Jun 30, 2024 | 1.62 Bn |
| Mar 31, 2024 | 1.55 Bn |
| Mar 31, 2024 | 1.55 Bn |
| Dec 31, 2023 | 1.74 Bn |
| Dec 31, 2023 | 1.74 Bn |